Skip to main content
. 2008 Jun 3;98(12):1944–1950. doi: 10.1038/sj.bjc.6604405

Table 4. Funding of the UK oncology research papers in 1999–2001, grouped by RL (integer counts); mean annual totals.

RL: ONCOL N(A) % of A GOV GOV, % PNP PNP, % CRUK CRUK, %
1–1.5 880 32 98 11 208 24 118 13
1.5–2 426 15 52 12 134 31 62 15
2–2.5 443 16 82 18 251 57 147 33
2.5–3 225 8 40 18 1247 55 55 24
3–3.5 330 12 77 23 189 57 99 30
3.5–4 452 16 163 36 300 66 163 36
Total 2756 100 511 19 1205 44 644 23
                 
RL: ONCOL N(A) % of A Pharm Pharm, % Ind'y Ind'y, % None None, %
1–1.5 880 32 53 6 25 3 527 60
1.5–2 426 15 39 9 17 4 200 47
2–2.5 443 16 71 16 20 4 96 22
2.5–3 225 8 22 10 70 3 48 21
3–3.5 330 12 43 13 17 5 43 13
3.5–4 452 16 65 15 20 4 37 8
Total 2756 100 294 11 106 4 950 35

A status=inspected papers; CRUK=Cancer Research UK; GOV=the UK government; Ind'y=other industry; Pharm=pharmaceutical industry; PNP=UK private nonprofit. Note: columns may not add correctly because of rounding.